Abiomed Inc's Pipeline Analysis for 2023 Reveals Clinical Advancement in Circulatory Support Technology
16 Jan 2024
DUBLIN, Jan. 16, 2024 /PRNewswire/ -- The "Abiomed Inc - Product Pipeline Analysis, 2023 Update" company profile has been added to
ResearchAndMarkets.com's offering.
Abiomed Inc (Abiomed) is a medical device company that develops, manufactures, and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
Report Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Abiomed Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Key Report Benefits:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Key Topics Covered:
Abiomed Inc
Abiomed Inc Company Snapshot
Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
Abiomed Inc - Pipeline Analysis Overview
Business Description
Abiomed Inc - Key Facts
Abiomed Inc - Major Products and Services
Abiomed Inc Pipeline Products by Development Stage
Abiomed Inc Ongoing Clinical Trials by Trial Status
Abiomed Inc Pipeline Products Overview
AbioCor II
AbioCor II Product Overview
Abiomed Breethe OXY-1 System
Abiomed Breethe OXY-1 System Product Overview
Abiomed Breethe OXY-1 System Clinical Trial
Artificial Intelligence Algorithm
Artificial Intelligence Algorithm Product Overview
Expandable Sheath - Heart Failure
Expandable Sheath - Heart Failure Product Overview
Impecmo
Impecmo Product Overview
Impella BTR
Impella BTR Product Overview
Impella BTR Clinical Trial
Impella ECP
Impella ECP Product Overview
Impella ECP Clinical Trial
Impella RP Flex with SmartAssist
Impella RP Flex with SmartAssist Product Overview
Impella XC
Impella XC Product Overview
Impella XR Sheath With Impella CP
Impella XR Sheath With Impella CP Product Overview
Next Generation Impella CP - STEMI
Next Generation Impella CP - STEMI Product Overview
Next Generation Impella CP - STEMI Clinical Trial
Symphony Heart Pump
Symphony Heart Pump Product Overview
Abiomed Inc
Abiomed Inc - Key Competitors
Abiomed Inc - Key Employees
Abiomed Inc - Key Employee Biographies
Abiomed Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Abiomed Inc, Recent Developments
Oct 23, 2023: Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium
Aug 17, 2023: Abiomed Recalls the Labeling for Impella RP Flex with SmartAssist for Risk of Blood Clots
Jul 27, 2023: Abiomed Recalls Nearly 8,000 Devices From Impella Pump Range
Jul 11, 2023: Abiomed Receives 510(k) Clearance for preCARDIA Occlusion System
Jun 14, 2023: Class 1 Device Recall Impella 2.5
Jun 05, 2023: Abiomed Recalls Specific Impella 5.5 with SmartAssist for Purge Fluid Leaks that Can Cause Pump Stop and Loss of Support
May 18, 2023: Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP During HRPCI
Apr 25, 2023: Pivotal Impella ECP study expands enrollment to three New Jersey hospitals
Mar 13, 2023: Breethe receives additional 510(k) clearance for Abiomed Breethe OXY-1 System
Feb 21, 2023: Breethe Announces Meditation & Stress App Provides Free Memberships to Those Who Have Been Laid Off
Company Coverage
Boston Scientific
LivaNova Plc
Edwards Lifesciences
Medtronic
Teleflex
Getinge
Terumo
For more information about this company profile visit https://www.researchandmarkets.com/r/cvzsg0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.